학술논문
Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky.
Document Type
Article
Author
Hamorsky, Krystal T.; Bushau-Sprinkle, Adrienne M.; Kitterman, Kathleen; Corman, Julia M.; DeMarco, Jennifer; Keith, Rachel J.; Bhatnagar, Aruni; Fuqua, Joshua L.; Lasnik, Amanda; Joh, Joongho; Chung, Donghoon; Klein, Jon; Flynn, Joseph; Gardner, Marti; Barve, Shirish; Ghare, Smita S.; Palmer, Kenneth E.
Source
Subject
*COVID-19 pandemic
*SERODIAGNOSIS
*IMMUNOGLOBULINS
*ENZYME-linked immunosorbent assay
*
*
*
Language
ISSN
2045-2322
Abstract
Serological assays intended for diagnosis, sero-epidemiologic assessment, and measurement of protective antibody titers upon infection or vaccination are essential for managing the SARS-CoV-2 pandemic. Serological assays measuring the antibody responses against SARS-CoV-2 antigens are readily available. However, some lack appropriate characteristics to accurately measure SARS-CoV-2 antibodies titers and neutralization. We developed an Enzyme-linked Immunosorbent Assay (ELISA) methods for measuring IgG, IgA, and IgM responses to SARS-CoV-2, Spike (S), receptor binding domain (RBD), and nucleocapsid (N) proteins. Performance characteristics of sensitivity and specificity have been defined. ELISA results show positive correlation with microneutralization and Plaque Reduction Neutralization assays with infectious SARS-CoV-2. Our ELISA was used to screen healthcare workers in Louisville, KY during the first wave of the local pandemic in the months of May and July 2020. We found a seropositive rate of approximately 1.4% and 2.3%, respectively. Our analyses demonstrate a broad immune response among individuals and suggest some non-RBD specific S IgG and IgA antibodies neutralize SARS-CoV-2. [ABSTRACT FROM AUTHOR]